Regulating cough through modulation of sensory nerve function in the airways

Pulmonary Pharmacology and Therapeutics

Volumn 26, Issue 5, 2013, Pages 486-490

  Spina, D ^a   Page, C P ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Afferent nerves; Cough; Local anaesthetic; Opioid; TRPA1; TRPV1

Indexed keywords

1 (2 BROMOPHENYL) 3 [1 (5 TRIFLUOROMETHYL 2 PYRIDINYL) 3 PYRROLIDINYL]UREA; ANTITUSSIVE AGENT; CAPSAICIN; CARCAINIUM CHLORIDE; CIGARETTE SMOKE; CITRIC ACID; GABAPENTIN; LIDOCAINE; LOCAL ANESTHETIC AGENT; MU OPIATE RECEPTOR; NOCICEPTIN; SCH 486757; SODIUM CHANNEL; THALIDOMIDE; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1; TYROSYL DEXTRO ARGINYLGLYCYL 4 NITROPHENYLALANYLPROLINAMIDE; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1;

AIRWAY; ARTICLE; BRONCHOSPASM; CHRONIC COUGH; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EFFECTIVENESS; CONSTIPATION; COUGHING; DRUG TARGETING; EVOKED RESPONSE; HUMAN; INFLAMMATION; LARYNGEAL NERVE; LOCAL ANESTHESIA; LUNG FIBROSIS; NERVE ENDING; NERVE FUNCTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATION DEPRESSION; SEDATION; SENSORY NERVE; SINGLE DRUG DOSE;

8-[BIS(2-CHLOROPHENYL)METHYL]-3-(2-PYRIMIDINYL)-8-AZABICYCLO[3.2.1.]OCTAN-3-OL; ACID SENSING ION CHANNEL; AFFERENT NERVES; ASIC; CARCANIUM CHLORIDE; CHRONIC OBSTRUCTIVE PULMONARY DISEASE; COPD; COUGH; LOCAL ANAESTHETIC; NOCICEPTIN/ORPHANIN OPIOID LIKE RECEPTOR 1; NOP1; OPIOID; RAPIDLY ADAPTING RECEPTOR; RAR; RSD931; SCH 486757; TRANSIENT RECEPTOR POTENTIAL ANKYRIN 1; TRANSIENT RECEPTOR POTENTIAL VANILLOID 1; TRPA1; TRPV1;

ANESTHETICS, LOCAL; ANIMALS; ANTITUSSIVE AGENTS; CHRONIC DISEASE; COUGH; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; GUINEA PIGS; HUMANS; MOLECULAR TARGETED THERAPY; NERVE FIBERS, MYELINATED; NERVE FIBERS, UNMYELINATED; SENSORY RECEPTOR CELLS;

EID: 84882713679     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2013.03.011     Document Type: Article

References (56)

1. Birring S.S. Controversies in the evaluation and management of chronic cough. Am J Respir Crit Care Med 2011, 183:708-715.
2. Widdicombe J.G. Neurophysiology of the cough reflex. Eur Respir J 1995, 8:1193-1202.
3. Canning B.J. Functional implications of the multiple afferent pathways regulating cough. Pulm Pharmacol Ther 2011, 24:295-299.
4. Tatar M., Webber S.E., Widdicombe J.G. Lung C-fibre receptor activation and defensive reflexes in anaesthetized cats. J.Physiol 1988, 402:411-420.
5. Tatar M., Sant'Ambrogio G., Sant'Ambrogio F.B. Laryngeal and tracheobronchial cough in anesthetized dogs. J.Appl. Physiol 1994, 76:2672-2679.
6. Key A.L., Holt K., Hamilton A., Smith J.A., Earis J.E. Objective cough frequency in idiopathic pulmonary fibrosis. Cough 2010, 6:4.
7. Groneberg D.A., Niimi A., Dinh Q.T., Cosio B., Hew M., Fischer A., et al. Increased expression of transient receptor potential vanilloid-1 in airway nerves of chronic cough. Am J Respir Crit Care Med 2004, 170:1276-1280.
8. Hope-Gill B.D., Hilldrup S., Davies C., Newton R.P., Harrison N.K. Astudy of the cough reflex in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2003, 168:995-1002.
9. Lieu T.M., Myers A.C., Meeker S., Undem B.J. TRPV1 induction in airway vagal low-threshold mechanosensory neurons by allergen challenge and neurotrophic factors. Am J Physiol Lung Cell Mol Physiol 2012, 302:L941-L948.
10. Steinhaus J.E., Gaskin L. Astudy of intravenous lidocaine as a suppressant of cough reflex. Anesthesiology 1963, 24:285-290.
11. Ing A.J., Ngu M.C., Breslin A.B. Pathogenesis of chronic persistent cough associated with gastroesophageal reflux. Am J Respir Crit Care Med 1994, 149:160-167.
12. Midgren B., Hansson L., Karlsson J.A., Simonsson B.G., Persson C.G. Capsaicin-induced cough in humans. Am Rev Respir Dis 1992, 146:347-351.
13. Reynolds S.M., Mackenzie A.J., Spina D., Page C.P. The pharmacology of cough. Trends Pharmacol Sci 2004, 25:569-576.
14. Young E.C., Smith J.A. Pharmacologic therapy for cough. Curr Opin Pharmacol 2011, 11:224-230.
15. Leffler A., Fischer M.J., Rehner D., Kienel S., Kistner K., Sauer S.K., et al. The vanilloid receptor TRPV1 is activated and sensitized by local anesthetics in rodent sensory neurons. JClin Invest 2008, 118:763-776.
16. Muroi Y., Ru F., Kollarik M., Canning B.J., Hughes S.A., Walsh S., et al. Selective silencing of Na(V)1.7 decreases excitability and conduction in vagal sensory neurons. JPhysiol 2011, 589:5663-5676.
17. Adcock J.J., Douglas G.J., Garabette M., Gascoigne M., Beatch G., Walker M., et al. RSD931, a novel anti-tussive agent acting on airway sensory nerves. Br J Pharmacol 2003, 138:407-416.
18. Fuller R.W., Karlsson J.A., Choudry N.B., Pride N.B. Effect of inhaled and systemic opiates on responses to inhaled capsaicin in humans. JAppl Physiol 1988, 65:1125-1130.
19. Adcock J.J., Schneider C., Smith T.W. Effects of codeine, morphine and a novel opioid pentapeptide BW443C, on cough, nociception and ventilation in the unanaesthetized guinea-pig. Br J Pharmacol 1988, 93:93-100.
20. Usmani O.S., Belvisi M.G., Patel H.J., Crispino N., Birrell M.A., Korbonits M., et al. Theobromine inhibits sensory nerve activation and cough. FASEB J 2005, 19:231-233.
21. Morice A.H., Menon M.S., Mulrennan S.A., Everett C.F., Wright C., Jackson J., et al. Opiate therapy in chronic cough. Am J Respir Crit Care Med 2007, 175:312-315.
22. Buchan P., Adcock J.J. Capsaicin-induced bronchoconstriction in the guinea-pig: contribution of vagal cholinergic reflexes, local axon reflexes and their modulation by BW443C81. Br J Pharmacol 1992, 105:448-452.
23. Choudry N.B., Gray S.J., Posner J., Fuller R.W. The effect of 443C81, a mu opioid receptor agonist, on the response to inhaled capsaicin in healthy volunteers. Br J Clin Pharmacol 1991, 32:633-636.
24. Belvisi M.G., Stretton C.D., Verleden G.M., Ledingham S.J., Yacoub M.H., Barnes P.J. Inhibition of cholinergic neurotransmission in human airways by opioids. JAppl Physiol 1992, 72:1096-1100.
25. Krajnik M., Schafer M., Sobanski P., Kowalewski J., Bloch-Boguslawska E., Zylicz Z., et al. Local pulmonary opioid network in patients with lung cancer: a putative modulator of respiratory function. Pharmacol Rep 2010, 62:139-149.
26. Zebraski S.E., Kochenash S.M., Raffa R.B. Lung opioid receptors: pharmacology and possible target for nebulized morphine in dyspnea. Life Sci 2000, 66:2221-2231.
27. Shah S., Page C.P., Spina D. Nociceptin inhibits non-adrenergic non-cholinergic contraction in guinea-pig airway. Br J Pharmacol 1998, 125:510-516.
28. Lee M.G., Undem B.J., Brown C., Carr M.J. Effect of nociceptin in acid-evoked cough and airway sensory nerve activation in guinea pigs. Am J Respir Crit Care Med 2006, 173:271-275.
29. McLeod R.L., Bolser D.C., Jia Y., Parra L.E., Mutter J.C., Wang X., et al. Antitussive effect of nociceptin/orphanin FQ in experimental cough models. Pulm Pharmacol Ther 2002, 15:213-216.
30. Bolser D.C., McLeod R.L., Tulshian D.B., Hey J.A. Antitussive action of nociceptin in the cat. Eur J Pharmacol 2001, 430:107-111.
31. McLeod R.L., Tulshian D.B., Sadeh J. Where are the new cough treatments: a debriefing of recent clinical proof-of-concept trials with the NOP agonist SCH 486757. Pharmacology 2011, 88:50-54.
32. Woodcock A., McLeod R.L., Sadeh J., Smith J.A. The efficacy of a NOP1 agonist (SCH486757) in subacute cough. Lung 2010, 188(Suppl. 1):S47-S52.
33. Watanabe N., Horie S., Michael G.J., Spina D., Page C.P., Priestley J.V. Immunohistochemical localization of vanilloid receptor subtype 1 (TRPV1) in the guinea pig respiratory system. Pulm Pharmacol Ther 2005, 18:187-197.
34. Watanabe N., Horie S., Michael G.J., Keir S., Spina D., Page C.P., et al. Immunohistochemical co-localization of transient receptor potential vanilloid (TRPV)1 and sensory neuropeptides in the guinea-pig respiratory system. Neuroscience 2006, 141:1533-1543.
35. Trevisani M. Antitussive activity of iodo-resiniferatoxin in guinea pigs. Thorax 2004, 59:769-772.
36. Andre E., Gatti R., Trevisani M., Preti D., Baraldi P.G., Patacchini R., et al. Transient receptor potential ankyrin receptor 1 is a novel target for pro-tussive agents. Br J Pharmacol 2009, 158:1621-1628.
37. Canning B.J., Spina D. Sensory nerves and airway irritability. Handb Exp Pharmacol 2009, 139-183.
38. Madison J.M., Irwin R.S. Chronic cough in adults with interstitial lung disease. Curr Opin Pulm Med 2005, 11:412-416.
39. Mazzone S.B., Mori N., Canning B.J. Synergistic interactions between airway afferent nerve subtypes regulating the cough reflex in guinea-pigs. JPhysiol 2005, 569:559-573.
40. Lutherer L.O., Nugent K.M., Schoettle B.W., Cummins M.J., Raj R., Birring S.S., et al. Low-dose oral interferon alpha possibly retards the progression of idiopathic pulmonary fibrosis and alleviates associated cough in some patients. Thorax 2011, 66:446-447.
41. El-Hashim A.Z., Jaffal S.M. Nerve growth factor enhances cough and airway obstruction via TrkA receptor- and TRPV1-dependent mechanisms. Thorax 2009, 64:791-797.
42. Prudon B., Birring S.S., Vara D.D., Hall A.P., Thompson J.P., Pavord I.D. Cough and glottic-stop reflex sensitivity in health and disease. Chest 2005, 127:550-557.
43. Paul I.M., Beiler J.S., King T.S., Clapp E.R., Vallati J., Berlin C.M. Vapor rub, petrolatum, and no treatment for children with nocturnal cough and cold symptoms. Pediatrics 2010, 126:1092-1099.
44. Laude E.A., Morice A.H., Grattan T.J. The antitussive effects of menthol, camphor and cineole in conscious guinea-pigs. Pulm Pharmacol 1994, 7:179-184.
45. Gaudioso C., Hao J., Martin-Eauclaire M.F., Gabriac M., Delmas P. Menthol pain relief through cumulative inactivation of voltage-gated sodium channels. Pain 2012, 153:473-484.
46. Xu H., Blair N.T., Clapham D.E. Camphor activates and strongly desensitizes the transient receptor potential vanilloid subtype 1 channel in a vanilloid-independent mechanism. JNeurosci 2005, 25:8924-8937.
47. Smith J.A., Murdoch R.D., Newlands A., Smart K., HKhalid S., Keslsall A., et al. The impact of a selective oral TRPV1 antagonist in patients with chronic cough. Thorax 2012, 67:A128.
48. Belvisi M.G., Dubuis E., Birrell M.A. Transient receptor potential A1 channels: insights into cough and airway inflammatory disease. Chest 2011, 140:1040-1047.
49. Moran M.M., McAlexander M.A., Biro T., Szallasi A. Transient receptor potential channels as therapeutic targets. Nat Rev Drug Discov 2011, 10:601-620.
50. Mazzone S.B., Reynolds S.M., Mori N., Kollarik M., Farmer D.G., Myers A.C., et al. Selective expression of a sodium pump isozyme by cough receptors and evidence for its essential role in regulating cough. JNeurosci 2009, 29:13662-13671.
51. Ryan N.M., Birring S.S., Gibson P.G. Gabapentin for refractory chronic cough: a randomised, double-blind, placebo-controlled trial. Lancet 2012, 380:1583-1589.
52. Horton M.R., Santopietro V., Mathew L., Horton K.M., Polito A.J., Liu M.C., et al. Thalidomide for the treatment of cough in idiopathic pulmonary fibrosis: a randomized trial. Ann Intern Med 2012, 157:398-406.
53. Rubin E.H., Gilliland D.G. Drug development and clinical trials-the path to an approved cancer drug. Nat Rev Clin Oncol 2012, 9:215-222.
54. Lee K.K., Matos S., Evans D.H., Pavord I.D., Birring S. Changes in cough frequency, cough severity and quality of life in acute cough. Am J Respir Crit Care Med 2012, 185:A5850.
55. Chong C.F., Chen C.C., Ma H.P., Wu Y.C., Chen Y.C., Wang T.L. Comparison of lidocaine and bronchodilator inhalation treatments for cough suppression in patients with chronic obstructive pulmonary disease. Emerg Med J 2005, 22:429-432.
56. McLeod R.L., Tulshian D.B., Bolser D.C., Varty G.B., Baptista M., Fernandez X., et al. Pharmacological profile of the NOP agonist and cough suppressing agent SCH 486757 (8-[Bis(2-Chlorophenyl)Methyl]-3-(2-Pyrimidinyl)-8-Azabicyclo[3.2.1]Octan-3-Ol) in preclinical models. Eur J Pharmacol 2010, 630:112-120.